Global burden of liver disease: 2023 update

Abstract

Liver disease accounts for two million deaths annually and is responsible for 4% of all deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related deaths occur in men. Deaths are largely attributable to complications of cirrhosis and hepatocellular carcinoma, with acute hepatitis accounting for a smaller proportion of deaths. The most common causes of cirrhosis worldwide are related to viral hepatitis, alcohol, and non-alcoholic fatty liver disease. Hepatotropic viruses are the aetiological factor in most cases of acute hepatitis, but drug-induced liver injury increasingly accounts for a significant proportion of cases. This iteration of the global burden of liver disease is an update of the 2019 version and focuses mainly on areas where significant new information is available like alcohol-associated liver disease, non-alcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma. We also devote a separate section to the burden of liver disease in Africa, an area of the world typically neglected in such documents.

Keywords

MeSH Terms

Affiliated Institutions

• London Health Sciences Centre CA
• Western University CA
• Baylor Medical Center at Garland US
• Baylor University Medical Center US
• Pontificia Universidad Católica de Chile CL
• Mayo Clinic US
• University of Cape Coast GH
• St.John's Medical College Hospital IN
• Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ES

Related Publications